These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metastatic colorectal cancer: is surgery necessary? Schmidt C. J Natl Cancer Inst; 2009 Aug 19; 101(16):1113-5. PubMed ID: 19671774 [No Abstract] [Full Text] [Related]
3. [Colorectal carcinoma: what's new?]. Pox C, Schmiegel W, Reinacher-Schick A. Dtsch Med Wochenschr; 2012 Dec 19; 137(49):2577-80. PubMed ID: 23188639 [No Abstract] [Full Text] [Related]
4. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, Brunetti IM, Ferraldeschi R, Naso G, Filipponi F, Pietrabissa A, Goletti O, Baldi G, Fornaro L, Andreuccetti M, Falcone A. Ann Surg; 2009 Mar 19; 249(3):420-5. PubMed ID: 19247029 [Abstract] [Full Text] [Related]
5. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T. Ann Surg Oncol; 2011 Feb 19; 18(2):421-30. PubMed ID: 20844968 [Abstract] [Full Text] [Related]
6. Prophylactic adjuvant hepatic arterial infusion chemotherapy reduced hepatic metastases from Stage III colorectal cancer after curative resection. Feng WM, Tang CW, Huang SX, Zheng YY, Bao Y, Wang Y, Tao YL. Hepatogastroenterology; 2012 Jun 19; 59(116):1087-90. PubMed ID: 22328287 [Abstract] [Full Text] [Related]
7. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, Shenyong Z, Bo X, Li L, Xiangou P, Haohao L, Lechi Y, Tianshu L, Jia F, Xinyu Q, Jianmin X. Ann Surg Oncol; 2012 Sep 19; 19(9):2860-8. PubMed ID: 22526903 [Abstract] [Full Text] [Related]
8. Chemotherapy of metastatic bowel cancer. Ross PJ, Cunningham D. Br J Hosp Med; 2012 Sep 19; 55(5):263-6. PubMed ID: 8777518 [No Abstract] [Full Text] [Related]
9. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M, gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol; 2005 Aug 01; 23(22):4881-7. PubMed ID: 16009952 [Abstract] [Full Text] [Related]
10. Oxaliplatin: a welcome addition to our therapeutic armamentarium. Chu E. Clin Colorectal Cancer; 2002 Aug 01; 2(2):72. PubMed ID: 12453318 [No Abstract] [Full Text] [Related]
11. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial. Leichman CG, Jacobson JR, Modiano M, Daniels JR, Zalupski MM, Doroshow JH, Fletcher WS, Macdonald JS. Cancer; 1999 Sep 01; 86(5):775-81. PubMed ID: 10463975 [Abstract] [Full Text] [Related]
12. Long-term outcome of unresectable metastatic colorectal cancer: does "adjuvant" chemotherapy play a role after resection? Power DG, Kemeny NE. Ann Surg; 2009 Oct 01; 250(4):654-5; author reply 655. PubMed ID: 19730229 [No Abstract] [Full Text] [Related]
13. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer. Dohn LH, Jensen BV, Larsen FO. Acta Oncol; 2010 Apr 01; 49(3):395-6. PubMed ID: 20001495 [No Abstract] [Full Text] [Related]
14. [First-line metastatic cancer of the colon]. Raoul JL. Gastroenterol Clin Biol; 2003 May 01; 27(5 Suppl):B150-3. PubMed ID: 12843951 [No Abstract] [Full Text] [Related]
15. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study. Mohammed TA, Dennie T, Holen KD. Clin Adv Hematol Oncol; 2011 Jun 01; 9(6):492-500. PubMed ID: 21841751 [No Abstract] [Full Text] [Related]
16. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer. Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M. In Vivo; 2006 Jun 01; 20(6A):743-6. PubMed ID: 17203759 [Abstract] [Full Text] [Related]
17. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer? Mayer RJ. J Clin Oncol; 2007 Sep 20; 25(27):4165-7. PubMed ID: 17709796 [No Abstract] [Full Text] [Related]
18. 5-fluorouracil, folinic acid and oxaliplatin administered via hepatic arterial infusion as regional second-line therapy for advanced colorectal cancer. Meyer L, Hildebrandt B, Riess H. Oncology; 2003 Sep 20; 64(4):473-4. PubMed ID: 12759548 [No Abstract] [Full Text] [Related]
19. [Two cases of long-term survival of metastatic colorectal cancer following treatment with polysaccharide K and mFOLFOX6 therapy]. Ohta K, Matsui S, Sato Y, Murao S. Gan To Kagaku Ryoho; 2012 Nov 20; 39(12):1782-4. PubMed ID: 23267885 [Abstract] [Full Text] [Related]
20. Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. Karacetin D, Yalcin B, Okten B, Ozturk S, Maral O, Incekara O. J BUON; 2009 Nov 20; 14(4):605-8. PubMed ID: 20148449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]